ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
କିଏ ଯୋଗ ଦେଇପାରିବେ ବୟସ୍କମାନେ
ବୟସ 18+ ବର୍ଷ
ଅଧ୍ୟୟନର ପ୍ରକାରଫେଜ୍ 3: ସାଧାରଣ ଚିକିତ୍ସା ସହିତ ତୁଳନା
What it testsଗୋଟେ medicine
କିଏ ଯୋଗ ଦେଇପାରିବେ ଆଉ କିଏ ପାରିବେ ନାହିଁ, ତାହାର ପୂରା ତାଲିକା ରେଜିଷ୍ଟ୍ରିରେ ଅଛି। ଟ୍ରାଏଲ୍ ଟିମ୍କୁ ପଚାରନ୍ତୁ, କିମ୍ବା ଆମକୁ ଲେଖନ୍ତୁ ଆଉ ଆମେ ଏହାକୁ ସହଜ ଭାଷାରେ ବୁଝେଇଦେବୁ।
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ 13 ଟି hospital ଭାରତରେ ରୋଗୀ ନେଉଛନ୍ତି।
Apollo Hospitals - Visakhapatnam - Health Cityବିଶାଖାପାଟଣା, ଆନ୍ଧ୍ରପ୍ରଦେଶଦିଗ ↗
Hemato Oncology Clinicଆହମ୍ମଦାବାଦ, ଗୁଜରାଟଦିଗ ↗
Marengo CIMS HospitalAhmedabad, GujaratDirections ↗
All India Institute of Medical SciencesNew Delhi, National Capital Territory of DelhiDirections ↗
Vardhman Mahavir Medical College and Safdarjung Hospitalନ୍ୟୁ ଦିଲ୍ଲୀ, ନ୍ୟାସନାଲ୍ କ୍ୟାପିଟାଲ୍ ଟେରିଟୋରି ଅଫ୍ ଦିଲ୍ଲୀଦିଗଦର୍ଶନ ↗
Rajiv Gandhi Cancer Institute And Research Centreନୂଆ ଦିଲ୍ଲୀ, ନ୍ୟାସନାଲ୍ କ୍ୟାପିଟାଲ୍ ଟେରିଟୋରୀ ଅଫ୍ ଦିଲ୍ଲୀଦିଗ ↗
Institute of Medical Sciences and Sum HospitalBhubaneswar, OdishaDirections ↗
Meenakshi Mission Hospital and Research Centreମାଦୁରାଇ, ତାମିଲନାଡୁଦିଗ ↗
Yashoda Hospitals - Hitech CityHyderabad, TelanganaDirections ↗
Mahamana Pandit Madan Mohan Malviya Cancer CentreVaranasi, Uttar PradeshDirections ↗
Narayana Superspecialty Hospitalହାଓଡ଼ା, ପଶ୍ଚିମବଙ୍ଗବାଟ ↗
Netaji Subhas Chandra Bose Cancer HospitalKolkata, West Bengalବାଟ ଦେଖାନ୍ତୁ ↗
Basavatarakam Indo American Cancer Hospital & Research Instituteହାଇଦ୍ରାବାଦଦିଗ ↗
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
ସ୍ପୋନ୍ସର: Mirati Therapeutics Inc.
NCT06875310 on ClinicalTrials.gov
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 13 Oct 2026 · ଆମ ଦ୍ୱାରା ପଢ଼ାଗଲା 20 Oct 2026